Laia Paré Brunet retweeted
Our work isn’t just about innovation—it’s about impact. We are dedicated to developing cutting-edge diagnostic tools that help define the best therapeutic options for patients with cancer, helping them receive the most effective treatment.
#WorldCancerDay
#precisiononcology
Laia Paré Brunet retweeted
Remarkable Milestones! 🎉 #HER2DX is on a roll, continuously adding valuable clinical evidence data! Here’s everything we’ve achieved so far—and we’re just getting started! Stay tuned for more advancements! 🚀 #HER2+ #precisiononology #breastcancer
More: ow.ly/YKZm50TV7QN
Laia Paré Brunet retweeted
On this day, we reaffirm our commitment to advancing research, innovation, and #precisiononcology. Every breakthrough brings us closer to better outcomes for #patients. #PrecisionOncology #Innovation #BreastCancerAwarenessMonth #HER2DX #DNADX #TNBCDX
Laia Paré Brunet retweeted
📢Development and validation of #TNBCDX a new genomic biomarker for early-stage triple-negative breast cancer with an without pembrolizumab.
Published in @Annals_Oncology
annalsofoncology.org/article…
@prat_aleix @VHIO @Laiapb @fara_bm @RevealGenomics
This Post is from an account that no longer exists. Learn more
Laia Paré Brunet retweeted
🎉 Celebrating 4 amazing years today! This milestone is just the beginning, thanks to our visionary leadership, committed team, and everyone who trusts us. We are dedicated to transforming cancer care to benefit patients. 🚀 #breastcancer #HER2DX #DNADX #TNBCDX
Laia Paré Brunet retweeted
#HER2DX makes its first appearance at #ESMO24! Dr @BarbaraPistill2
#precisiononcology
#breastcancer
#ESMO2024
Laia Paré Brunet retweeted
⭐️⭐️⭐️⭐️⭐️We are proud to have one of the best among us. Our CSO & co-founder @prat_aleix has been recognized by @Forbes_es as one of the 100 best doctors in Spain. (Article in Spanish)
ow.ly/51W350T9Jh2
#precisiononcology
#HER2DX
Laia Paré Brunet retweeted
Poster 74P - #ESMOBreast24 Assessing the Implementation of the #HER2DX Genomic Test in a Real-World Setting for HER2+ #breastcancer
@CejalvoM @badamo20
👉🏻 #HER2DX is being used across multiple scenarios. The #HER2DX scores provides new insights for patients.
Laia Paré Brunet retweeted
Poster 12P - #ESMOBreast24 Updated findings from the first prospective #HER2DX clinical decision impact study on early-stage #HER2+ #breastcancer @OlgaMartnezSez1
👉🏻#HER2DX influenced clinical management in early stages of HER2+, increasing physicians' confidence
Laia Paré Brunet retweeted
This photo doesn't capture everyone, but it offers a glimpse into the remarkable women on our team. Each day, we passionately work to enhance and improve the lives of patients with #breastcancer Let’s build a more equal and just world! #InternationalWomensDay #WomensDay #IWD2024
Laia Paré Brunet retweeted
Introducing the DEFINITIVE project: #HER2DX first prospective trial, led by @idibaps, conducted across 44 hospitals in a total of 7 European and associated countries. funded by European Commission’s key funding program for research and innovation👉🏻 ow.ly/bskq50QJs55
Laia Paré Brunet retweeted
HER2DX to undergo first prospective trial in 7 🇪🇺 countries, supported by a 8M Horizon Europe grant. Congrats to the @RevealGenomics team and co-PIs @TomasPascualMD & @OlgaMartnezSez1 for initiating this important effort! biospace.com/article/release… – at Boston, MA
Laia Paré Brunet retweeted
Our CSO & co-founder, @prat_aleix received the National Research Award "Doctores Diz Pintado" His exceptional work, including our groundbreaking test #HER2DX, has earned him this prestigious honor. Read about his achievements! 👉🏻
ow.ly/aFFX50QuMxr
#precisiononcology
Laia Paré Brunet retweeted
#SABCS23 | Poster PO3-16-03 | Investigating #HER2DX genomic assay concordance within HER2-positive #breastcancer. @fara_bm @adawaksmd @stolaney1 @Otto_DFCI @LabPolyak @Laiapb @G_Villacampa @prat_aleix @esther_sanfeliu @AnaVivancosVHIO
Laia Paré Brunet retweeted
More evidence of clinical utility of #HER2DX for patients with esrly-stage HER2-positive #breastcancer
This Post is from an account that no longer exists. Learn more
Laia Paré Brunet retweeted
Dr @JavierCortesMD on PHERGain study explaining our collaboration with @wearemedsir
#HER2DX
#breastcancer
#precisiononcology
#ESMO23 – at Barcelona, Spain
@JavierCortesMD highlighted the MEDSIR's #ESMO23 congress, emphasizing the importance of translational studies within the PHERGain project.
Discover more about our studies presented at ESMO, guided by Dr. Cortés.
#ESMO23 #CancerReseacrh #ClinicalTrials #Oncology
Laia Paré Brunet retweeted
On #WorldBreastCancer Day, we reiterate our commitment to innovation and finding answers for patients; this is what guides our daily work.
#BreastCancerAwarenessMonth
#breastcancer
#precisiononcology
#HER2DX
Laia Paré Brunet retweeted
Very encouraging results from the #HER2DX analysis of PHERGain. HER2DX-pCR score was significantly associated with pCR rates and eight out of nine patients experiencing metastatic progression had HER2DX high risk disease (❗️). Deserved more than a poster presentation IMO. #ESMO23
Laia Paré Brunet retweeted
“Tackling diversity in HER2-positive breast cancer: biological and clinical implications” @TomasPascualMD on #HER2DX pCR score and drug response at @ACCMEDorg #HER2DX is the world’s first diagnostic test specifically for HER2+ #breastcancer More info: ow.ly/sMFl50POgSO
